Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 3/2016

01-06-2016 | Review Article

Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015—Part 2 of 2: Myocardial perfusion imaging

Authors: Fadi G. Hage, MD, FASH, FACC, FASNC, Wael A. AlJaroudi, MD, FACC, FAHA, FESC, FASNC

Published in: Journal of Nuclear Cardiology | Issue 3/2016

Login to get access

Abstract

In 2015, the Journal of Nuclear Cardiology ® published many high-quality articles. In this series, we will summarize key articles that have appeared in the Journal last year to provide for the interested reader a quick review of the advancements that have recently occurred in the field. In the first article of this 2-part series, we concentrated on publications dealing with plaque imaging, cardiac positron emission tomography, computed tomography, and magnetic resonance. This review will focus on myocardial perfusion imaging summarizing advances in the field including in diagnosis, prognosis, and appropriate use.
Literature
1.
AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance. J Nucl Cardiol 2015. doi: 10.​1007/​s12350-015-0319-9.
2.
AlJaroudi WA, Hage FG. Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 1 of 2: Positron emission tomography, computed tomography, and neuronal imaging. J Nucl Cardiol 2015;22:507-12.CrossRefPubMed
3.
Hage FG, AlJaroudi WA. Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging. J Nucl Cardiol 2015;22:714-9.CrossRefPubMed
4.
5.
Beale C, Tilkemeier P. Understanding the past to appropriately guide us in the future. J Nucl Cardiol 2015
6.
Mahajan A, Bal S, Hahn H. Myocardial perfusion imaging determination using an appropriate use smartphone application. J Nucl Cardiol 2015;22:66-71.CrossRefPubMed
7.
8.
9.
Iqbal FM, Hage FG, Ahmed A, Dean PJ, Raslan S, Heo J, et al. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. JACC Cardiovasc Imaging 2012;5:1014-21.CrossRefPubMed
10.
Hage FG, Ghimire G, Lester D, McKay J, Bleich S, El-Hajj S, et al. The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol 2015;22:1214-21.CrossRefPubMed
11.
Farzaneh-Far A, Shaw LK, Dunning A, Oldan JD, O’Connor CM, Borges-Neto S. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. J Nucl Cardiol 2015;22:600-7.CrossRefPubMed
12.
Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol 2012;19:1026-43.CrossRefPubMed
13.
Doukky R. The prognostic value of regadenoson stress: Has the case been made? J Nucl Cardiol 2015;22:608-10.CrossRefPubMed
14.
Acampa W, Salvatore M, Cuocolo A. Prognostication in the era of a new stressor for myocardial perfusion imaging. J Nucl Cardiol 2015;22:1222-4.CrossRefPubMed
15.
Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2011;18:1086-94.CrossRefPubMed
16.
17.
AlJaroudi W, Campagnoli T, Fughhi I, Wassouf M, Ali A, Doukky R. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0234-0.
18.
Romero-Farina G, Candell-Riera J, Ferreira-Gonzalez I, Aguade-Bruix S, Pizzi N, Garcia-Dorado D. Normal myocardial perfusion gated SPECT and positive stress test: Different prognoses in women and men. J Nucl Cardiol 2015;22:453-65.CrossRefPubMed
19.
Hage FG, Dubovsky EV, Heo J, Iskandrian AE. Outcome of patients with adenosine-induced ST-segment depression but with normal perfusion on tomographic imaging. Am J Cardiol 2006;98:1009-11.CrossRefPubMed
20.
Nakanishi R, Gransar H, Slomka P, Arsanjani R, Shalev A, Otaki Y, et al. Predictors of high-risk coronary artery disease in subjects with normal SPECT myocardial perfusion imaging. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0150-3.PubMedCentral
21.
22.
Lester D, El-Hajj S, Farag AA, Bhambhvani P, Tauxe L, Heo J, et al. Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0272-7.
23.
Golzar Y, Olusanya A, Pe N, Dua SG, Golzar J, Gidea C, et al. The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol 2015;22:526-34.CrossRefPubMed
24.
25.
Bourque JM. Contemporary relevance of TID: Based on the company it keeps. J Nucl Cardiol 2015;22:535-8.CrossRefPubMed
26.
Vitola JV, Wanderley MR Jr, Cerci RJ, Pereira Neto CC, Kormann O, Neto OF, et al. Outcome of patients with high-risk Duke treadmill score and normal myocardial perfusion imaging on spect. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0156-x.PubMed
27.
28.
Koh AS, Gao F, Chin CT, Keng FY, Tan RS, Chua TS. Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0253-x.PubMed
29.
Nudi F, Schillaci O, Neri G, Pinto A, Procaccini E, Vetere M, et al. Prognostic impact of location and extent of vessel-related ischemia at myocardial perfusion scintigraphy in patients with or at risk for coronary artery disease. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0077-8.PubMed
30.
31.
El-Hajj S, AlJaroudi WA, Farag A, Bleich S, Manaoragada P, Iskandrian AE, et al. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0174-8.
32.
Petretta M, Salvatore M, Cuocolo A. Immortality time and serial myocardial perfusion imaging: Only those who do not die may repeat the exam. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0171-y.
33.
34.
Iskandrian AE, Hage FG, Shaw LJ, Mahmarian JJ, Berman DS. Serial myocardial perfusion imaging: Defining a significant change and targeting management decisions. JACC Cardiovasc Imaging 2014;7:79-96.CrossRefPubMed
35.
36.
37.
Sharir T, Pinskiy M, Pardes A, Rochman A, Prokhorov V, Kovalski G, et al. Comparison of the diagnostic accuracies of very low stress-dose with standard-dose myocardial perfusion imaging: Automated quantification of one-day, stress-first SPECT using a CZT camera. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0130-7.PubMed
38.
39.
Nakazato R, Slomka PJ, Fish M, Schwartz RG, Hayes SW, Thomson LE, et al. Quantitative high-efficiency cadmium-zinc-telluride SPECT with dedicated parallel-hole collimation system in obese patients: Results of a multi-center study. J Nucl Cardiol 2015;22:266-75.CrossRefPubMedPubMedCentral
40.
Blankstein R. Can advances in nuclear cardiology hardware overcome the challenges of imaging obese patients? J Nucl Cardiol 2015;22:276-8.CrossRefPubMed
Metadata
Title
Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015—Part 2 of 2: Myocardial perfusion imaging
Authors
Fadi G. Hage, MD, FASH, FACC, FASNC
Wael A. AlJaroudi, MD, FACC, FAHA, FESC, FASNC
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 3/2016
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0444-0

Other articles of this Issue 3/2016

Journal of Nuclear Cardiology 3/2016 Go to the issue

Original Article

Impact of incomplete revascularization of coronary artery disease on long-term cardiac outcomes. Retrospective comparison of angiographic and myocardial perfusion imaging criteria for completeness

Original Article

Comparison of biventricular ejection fractions using cadmium-zinc-telluride SPECT and planar equilibrium radionuclide angiography

WHAT IS THIS IMAGE?

What is this image? 2016—Image 1

CME Article Review Article

The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging

Original Article

A study to quantify the effect of patient motion and develop methods to detect and correct for motion during myocardial perfusion imaging on a CZT solid-state dedicated cardiac camera

Original Article

Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits